CD80 and cancer: In our study, we have identified two groups of patients based on the B7 phenotype that display T cell maturation profiles and ICR expression patterns that can be successfully reconciled with literature data regarding the immune pathogenesis of “inflamed” and “non-inflamed” cancer immune profiles.